Our results display that both T cells and ILCs seem to contribute to the production of IL-5 and IL-13 when OVA in alum induced asthma, suggesting both immune response pathways of Th2 cells and ILCs can be therapeutic targets for preventing or treating asthma. This evidence concerns the gene IL5 and asthma.